GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolio
January 07, 2019 at 13:05 PM EST
After announcing two major deals last month, GlaxoSmithKline CEO Emma Walmsley is still looking for more chances to transform Britain's largest drugmaker.
